학술논문
EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA-AMYLOID 42 (Aβ42)-SPECIFIC ANTIBODY, IN PATIENTS WITH MILD-MODERATE ALZHEIMER'S DISEASE
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2017 13(7) Supplement:P574-P574
Subject
Language
ISSN
1552-5260